Resistance Training — The Sarcopenia Antidote

Resistance training induces mechanical tension, muscle damage, and metabolic stress, which activate the mechanistic target of rapamycin complex 1 (mTORC1) pathway. This activation stimulates muscle protein synthesis and hypertrophy. It also enhances insulin sensitivity by increasing the translocation of GLUT4 transporters to the muscle cell membrane, independent of insulin. Furthermore, it stimulates osteoblast activity, increasing bone mineral density, and promotes the release of myokines that exert systemic anti-inflammatory effects.

Extensive human evidence demonstrates that resistance training significantly improves muscle mass, strength, and functional capacity in older adults. Large epidemiological studies consistently link regular resistance training with a reduced risk of all-cause mortality, cardiovascular disease, and type 2 diabetes. Clinical trials show it effectively mitigates sarcopenia and improves metabolic health markers across various age groups.

Current guidelines recommend 2–3 sessions per week on non-consecutive days, targeting all major muscle groups. Protocols typically involve 2–4 sets of 8–12 repetitions per exercise at an intensity of 60–80% of one-repetition maximum (1RM). Progressive overload is essential for continued adaptation.

Generally safe for most individuals when performed with proper form and appropriate progression. Risks include musculoskeletal injuries, particularly if lifting excessively heavy weights or using poor technique. Individuals with severe cardiovascular disease, uncontrolled hypertension, or severe osteoporosis should consult a physician before initiating a high-intensity program.

Key Papers